Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-04-25 AGM Information
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司关于召开2021年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2021 Annual General Meeting (AGM) of the company 南微医学科技股份有限公司. It includes information about the meeting date, voting methods, agenda items to be discussed and voted on, registration procedures, and other logistical details. The document does not contain financial statements or detailed financial analysis but rather serves as an official announcement and invitation to shareholders to attend and vote at the AGM. The document length is 3821 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself.
2022-04-25 Chinese
南微医学科技股份有限公司2022年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2022 年第一季度报告' which translates to '2022 First Quarter Report'. It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes for the first quarter of 2022. The report is unaudited as indicated. It includes comprehensive financial metrics, shareholder information, and operational highlights for the quarter. The length is over 13,000 characters, indicating a full report rather than a brief announcement. The content matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive analysis. Therefore, the document should be classified as an Interim / Quarterly Report (IR). Q1 2022
2022-04-25 Chinese
南微医学科技股份有限公司2021年业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2021年度业绩快报公告" which translates to "2021 Annual Performance Express Report Announcement." It contains preliminary financial data for the year 2021, including revenue, profit, and other key financial metrics. The data is explicitly stated as preliminary and unaudited, with a note that the final audited data will be in the 2021 Annual Report. The document is relatively short (1920 characters) and serves as an initial earnings summary rather than a full detailed report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or annual financial results with key highlights only. It is not the full Annual Report (10-K), nor is it a report publication announcement (RPA) because it contains substantive financial data, not just a notice of report availability. FY 2021
2022-02-25 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司2021年度持续督导工作现场检查报告
Regulatory Filings
2022-01-05 Chinese
南微医学科技股份有限公司2021年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the company's third extraordinary general meeting of shareholders in 2021. It details the meeting date, attendance, voting results on specific proposals, and legal compliance statements. There is no indication of it being a full report like an annual or interim report, nor is it a presentation or earnings release. The content focuses on the official announcement of voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and it is not merely announcing a report publication but providing detailed voting results and resolutions passed.
2021-12-30 Chinese
江苏新高的律师事务所关于南微医学2021年第三次临时股东大会的见证法律意见书
Regulatory Filings
2021-12-30 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.